Gudmundur Johannsson

Research interests

Publications

• Consensus on criteria for acromegaly diagnosis and remission

  Pituitary · 2023 · https://doi.org/10.1007/s11102-023-01360-1

• Clinical Biology of the Pituitary Adenoma

  Endocrine Reviews · 2022 · https://doi.org/10.1210/endrev/bnac010

• Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology

  JAMA Neurology · 2019 · https://doi.org/10.1001/jamaneurol.2019.1534

• Non-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management

  Pituitary · 2019 · https://doi.org/10.1007/s11102-019-00960-0

• Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016

  European Journal of Endocrinology · 2018 · https://doi.org/10.1530/eje-17-0933

• Hypopituitarism

  The Lancet · 2016 · https://doi.org/10.1016/s0140-6736(16)30053-8

• Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide

  The Journal of Clinical Endocrinology & Metabolism · 2015 · https://doi.org/10.1210/jc.2014-4350

• GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults

  European Journal of Endocrinology · 2015 · https://doi.org/10.1530/eje-15-0873

• Excess Mortality and Morbidity in Patients with Craniopharyngioma, Especially in Patients with Childhood Onset: A Population-Based Study in Sweden

  The Journal of Clinical Endocrinology & Metabolism · 2014 · https://doi.org/10.1210/jc.2014-3525

• Deaths Among Adult Patients With Hypopituitarism: Hypocortisolism During Acute Stress, and De Novo Malignant Brain Tumors Contribute to an Increased Mortality

  The Journal of Clinical Endocrinology & Metabolism · 2013 · https://doi.org/10.1210/jc.2012-4059

• The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations

  Nature Reviews Endocrinology · 2013 · https://doi.org/10.1038/nrendo.2013.64

• Improved Cortisol Exposure-Time Profile and Outcome in Patients with Adrenal Insufficiency: A Prospective Randomized Trial of a Novel Hydrocortisone Dual-Release Formulation

  The Journal of Clinical Endocrinology & Metabolism · 2011 · https://doi.org/10.1210/jc.2011-1926

• Role of the GH/IGF-1 axis in lifespan and healthspan: Lessons from animal models

  Growth Hormone & IGF Research · 2008 · https://doi.org/10.1016/j.ghir.2008.05.005

• Management of the Child Born Small for Gestational Age through to Adulthood: A Consensus Statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society

  The Journal of Clinical Endocrinology & Metabolism · 2007 · https://doi.org/10.1210/jc.2006-2017

• Premature Mortality in Patients with Addison’s Disease: A Population-Based Study

  The Journal of Clinical Endocrinology & Metabolism · 2006 · https://doi.org/10.1210/jc.2006-0076

• The Impact of Glucocorticoid Replacement Regimens on Metabolic Outcome and Comorbidity in Hypopituitary Patients

  The Journal of Clinical Endocrinology & Metabolism · 2006 · https://doi.org/10.1210/jc.2006-0524

• Estrogen Regulation of Growth Hormone Action

  Endocrine Reviews · 2004 · https://doi.org/10.1210/er.2003-0035

• Malignant Disease and Cardiovascular Morbidity in Hypopituitary Adults with or without Growth Hormone Replacement Therapy

  The Journal of Clinical Endocrinology & Metabolism · 2004 · https://doi.org/10.1210/jc.2003-031601

• Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist

  The Lancet · 2001 · https://doi.org/10.1016/s0140-6736(01)06844-1

• A Prospective Study of 5 Years of GH Replacement Therapy in GH-Deficient Adults: Sustained Effects on Body Composition, Bone Mass, and Metabolic Indices

  The Journal of Clinical Endocrinology & Metabolism · 2001 · https://doi.org/10.1210/jcem.86.10.7887

• Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant

  New England Journal of Medicine · 2000 · https://doi.org/10.1056/nejm200004203421604

• Growth Hormone Treatment of Abdominally Obese Men Reduces Abdominal Fat Mass, Improves Glucose and Lipoprotein Metabolism, and Reduces Diastolic Blood Pressure1

  The Journal of Clinical Endocrinology & Metabolism · 1997 · https://doi.org/10.1210/jcem.82.3.3809

• Growth Hormone Treatment of Abdominally Obese Men Reduces Abdominal Fat Mass, Improves Glucose and Lipoprotein Metabolism, and Reduces Diastolic Blood Pressure

  The Journal of Clinical Endocrinology & Metabolism · 1997 · https://doi.org/10.1210/jc.82.3.727

• The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender.

  The Journal of Clinical Endocrinology & Metabolism · 1996 · https://doi.org/10.1210/jcem.81.4.8636370

• Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency.

  The Journal of Clinical Endocrinology & Metabolism · 1996 · https://doi.org/10.1210/jcem.81.8.8768843

Current projects

No projects listed.